Atag, E. Et Al. 2017. Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2 , 57-62.

Atag, E., KARAOĞLU, A., & Kucuk, O., (2017). Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, 57-62.

Atag, ELİF, AZİZ KARAOĞLU, And Omer Kucuk. "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer," UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, 57-62, 2017

Atag, ELİF A. Et Al. "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62, 2017

Atag, E. KARAOĞLU, A. And Kucuk, O. (2017) . "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62.

@article{article, author={ELİF ATAĞ AKYÜREK Et Al. }, title={Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer}, journal={UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY}, year=2017, pages={57-62} }